CORT  valuation analysis

Basics
Name: Corcept Therapeutics Incorporated
Description: Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 05, 2022
Market cap: $2.29B (981st)
Sales(TTM): $380.23M (1288th)
Earnings(TTM): $111.84M (954th)

Value
FFER: 1.23 (why)
Actual price: $19.94
FFEThis is Corcept Therapeutics Incorporated's the estimated price. FFEs are the denominator of the FFER ratio.: $16.27
Quantile: CORT is expensive given its fundamentals.
Prices as of EOD 2022-05-25
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Corcept Therapeutics Incorporated
"Biotechnology" industry
Sales / MarketCap
Corcept Therapeutics Incorporated
"Biotechnology" industry
Book / MarketCap
Corcept Therapeutics Incorporated
"Biotechnology" industry
Equity / Assets
Corcept Therapeutics Incorporated
"Biotechnology" industry